Abstract
The clinical presentations of children and adults with bacterial meningitis have not changed over the past several decades, and a high index of suspicion remains critical for timely identification of infected patients. With the virtual disappearance of H. influenzae type B meningitis (Hib) in areas of the world where Hib conjugate vaccine is administered routinely, the utility of commercially available tests for rapid detection of bacterial polysaccharides has diminished. Detection of gene products of meningeal pathogens in cerebrospinal fluid or blood is still experimental. The prognostic findings of recent studies are not different from those previously described, despite advances in the supportive care of critically ill patients.
Original language | English (US) |
---|---|
Pages (from-to) | 579-594 |
Number of pages | 16 |
Journal | Infectious Disease Clinics of North America |
Volume | 13 |
Issue number | 3 |
DOIs | |
State | Published - 1999 |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases